{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2l","columns":[{"gene":"","key":"population-247f283f6bbdb813593d","label":"Muscular dystrophy, limb-girdle, type 2L","mondoId":"MONDO:0012652","onsetQualifier":null,"originColumnKey":"MONDO:0012652/OMIM:611307","originalViews":[{"key":"MONDO:0012652/OMIM:611307","label":"Muscular dystrophy, limb-girdle, type 2L","scopeLabel":"OMIM:611307","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["0b232a3e9d9f336362f5548c177b15c75cadbc8f5209b1d11fba8c24610fe239","1d4a5b316e429d357b4ffda8609280790349421da793d00b6e101ff1334addac","2a9a38e27e6b9e632e304a3d159715186b789334280fc5b29805c6947c7f67c2","799bf39dd3527a4655ba759f37924f32ce88805fc00c2e4c907303da7992c53e","95046e7e8d3be772aeaa217bd833f88e8cb1c3ce1d3fa8509a9a884a0524159b","97ba07d86346667bfc006657068428613218e184f9f89f5ed0f8d6a1aedb326a","9fa1590a795f0aace276badc67656b1560bf845f8cabbc54790c507a74819294","ab52d5b918646968c0a8299555d8833151d9723b72a58bb25622cc9eb178ea09","ede150515d7641817b825b6f7a3132efa181d8dda751c53fd6fd892d0321ddd2","f0bbc5cf52d2a7b69f355c7da3422d1427159dade4e9a5cd2f1d9fc2541ba327","fd7b48e5f694a95d06120c0f36adc3bf099b0283ea5abee3a92e1598a34aa361"],"recordQualifiers":{},"scopeLabel":"OMIM:611307","sourceIds":["OMIM:611307"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-1e29327f424d1e36b1c3","label":"Anoctamin-5-related limb-girdle muscular dystrophy R12","mondoId":"MONDO:0012652","onsetQualifier":null,"originColumnKey":"MONDO:0012652/ORPHA:206549","originalViews":[{"key":"MONDO:0012652/ORPHA:206549","label":"Anoctamin-5-related limb-girdle muscular dystrophy R12","scopeLabel":"ORPHA:206549","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["01d6fbf42f390010f718369683687cef145217083f113f0904d0fcab98615866","0329096c53dafefc0ad50f6c0c3527e5149cb187f64cede35de9b2bc8307fde8","0e90838491f53a6a6521f9919fa88a39efe62b39f9ab7d6749878e3f1daf1432","13001241d627d9ffe344e73bba5d283e9f165ef9d92ef31abe89d3cdddfca438","147f3eb15d664adf2de829ae1dbb3679ff3fb9a7d9076ec550444b81e29cdebe","1adc12fe168274c2bf4a0cc1b9362eae7190875ca742f556ebe369d1fc649510","290320c0c430593b711ac8532680c524e2222497aca81266442db6764a83a3dd","2dde50dcbacf3f4a1a2b724261d5a576d22011b2ca9e83ed55f7536b2af16abf","387a888eca9b4431dc13b39f971e8b8faa7fa73bac234eab1870ed597c553644","473f8293b31a54a2a5529c6187421ee94c4ca50dc566d6fa681f943d2db95adf","49622da485569dd12f6ccb335ea74d62eb63e39871ae2f08885835ebc637a733","4bb8aa67f617c38fe67808f132c1bcdd46fddd49087eeb8aa79960c29a5a4f3f","5346140069a419c6f09cde66d0e268238e3b14a4a20d7017807d8dee2a8c54c1","61306359e34a26279371c49116e28df35db45bf1027fa81a2dfd5b3b7410fbf1","6c7ae4f5e530546fb2a5f5df89e463e30b74f067411118bfe3874e5799b07b16","768cf16c9846629f425bab10ad29f4522deaa341c539d98fcea1b8500b44a365","7a82d13e0f16ec092da819aaf8e3a830c5766506f3b665a6ed827e4b645d7a68","7ceba7a4f158c59416186a2775acbc96a22aaf88fb13c6f22787fe30d9403427","8719691e22efab205ef58f543ec25f1275290214a01a142c3d65b4f84baeb79b","87c74575193596944fb631166f320f189c905d2ac6b6f6f61d731b11101e03f6","8ba44e0b2a479d57ac99f01598668310377a899f8ea40c08c4ed0d55ebf4fb7f","8f430c4037e90925c74580a46459b4445a797421a8ca0369ac458ea4995ee214","9c9291870ded50f73cce56dfc7b8e8d62be7556077affe174d20cd69886ded6a","a19afce354b99dc8d3865ba651d74e7f2e4a0af47b618ff55317f44bd860c0cb","b4d177e3597687493481d647de1ccefc733e326a29116cdb27234d54c9625f00","b810b5778a04c39d92adaa6fdb23ce38e0227cff198e8a5bd79e71dfc63e6517","b9ae9d8893a74b944f6e3ee563be51be8eb0097061c888c13156a0f55cdefeea","c8000a8a6dd106fbcbbfde05846ebea8766587667c548a28d52f4e7ac5ca73da","c801b509d9d49ad7e76ab39c76aecd841a30a28f0f8fd46720446f9b3a127609","cafbc823e5cc103579b346ebb434a6f30c64c82d272e6e133caefd24e56dae5c","cd8b530c1789cdd4763e93ae825e0832fc3b0bd8c538bba27bc3cdf022b287d3","e917269beff2326c23f06a5c51974d3200a01a71a12430d990b55e3fa76a57ee","f0a76620cfc8b56d680874b837981bce1ea6d3c22b3b6993c1266e9b9fdd5122","fa54f1b5753b5f2e519412429b6851f7767d6999d7660d93cf04a7f3b7d85861","fd8446f2439022bfc671bbc42b4998c41865e6bb7ab5906735bb4cf5d5ad7b67"],"recordQualifiers":{},"scopeLabel":"ORPHA:206549","sourceIds":["ORPHA:206549"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-247f283f6bbdb813593d","population-1e29327f424d1e36b1c3"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001430","HP:0004303","HP:0006466","HP:0008981","HP:0001638","HP:0009053","HP:0002987"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":5,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":46,"sourceGroups":{"omim":5,"orphanet":35,"published":6}},"features":[{"hpoId":"HP:0001430","label":"Abnormal calf musculature morphology","primary":true},{"hpoId":"HP:0004303","label":"Abnormal muscle fiber morphology","primary":true},{"hpoId":"HP:0006466","label":"Ankle flexion contracture","primary":true},{"hpoId":"HP:0008981","label":"Calf muscle hypertrophy","primary":true},{"hpoId":"HP:0001638","label":"Cardiomyopathy","primary":true},{"hpoId":"HP:0009053","label":"Distal lower limb muscle weakness","primary":true},{"hpoId":"HP:0002987","label":"Elbow flexion contracture","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0003482","label":"EMG: axonal abnormality","primary":false},{"hpoId":"HP:0003458","label":"EMG: myopathic abnormalities","primary":false},{"hpoId":"HP:0003730","label":"EMG: myotonic runs","primary":false},{"hpoId":"HP:0003445","label":"EMG: neuropathic changes","primary":false},{"hpoId":"HP:0003738","label":"Exercise-induced myalgia","primary":false},{"hpoId":"HP:0010628","label":"Facial palsy","primary":false},{"hpoId":"HP:0012548","label":"Fatty replacement of skeletal muscle","primary":false},{"hpoId":"HP:0001371","label":"Flexion contracture","primary":false},{"hpoId":"HP:0012785","label":"Flexion contracture of finger","primary":false},{"hpoId":"HP:0002816","label":"Genu recurvatum","primary":false},{"hpoId":"HP:0003089","label":"Hamstring contractures","primary":false},{"hpoId":"HP:0009025","label":"Increased connective tissue","primary":false},{"hpoId":"HP:0100297","label":"Increased endomysial connective tissue","primary":false},{"hpoId":"HP:0003557","label":"Increased variability in muscle fiber diameter","primary":false},{"hpoId":"HP:0031237","label":"Internally nucleated skeletal muscle fibers","primary":false},{"hpoId":"HP:0006785","label":"Limb-girdle muscular dystrophy","primary":false},{"hpoId":"HP:0007210","label":"Lower limb amyotrophy","primary":false},{"hpoId":"HP:0100295","label":"Muscle fiber atrophy","primary":false},{"hpoId":"HP:0003555","label":"Muscle fiber splitting","primary":false},{"hpoId":"HP:0003560","label":"Muscular dystrophy","primary":false},{"hpoId":"HP:0003326","label":"Myalgia","primary":false},{"hpoId":"HP:0002913","label":"Myoglobinuria","primary":false},{"hpoId":"HP:0008988","label":"Pelvic girdle muscle atrophy","primary":false},{"hpoId":"HP:0003749","label":"Pelvic girdle muscle weakness","primary":false},{"hpoId":"HP:0008994","label":"Proximal lower limb muscle weakness","primary":false},{"hpoId":"HP:0003701","label":"Proximal muscle weakness","primary":false},{"hpoId":"HP:0008997","label":"Proximal upper limb muscle weakness","primary":false},{"hpoId":"HP:0009050","label":"Quadriceps muscle atrophy","primary":false},{"hpoId":"HP:0003691","label":"Scapular winging","primary":false},{"hpoId":"HP:0003547","label":"Shoulder girdle muscle weakness","primary":false},{"hpoId":"HP:0009129","label":"Upper limb amyotrophy","primary":false},{"hpoId":"HP:0001239","label":"Wrist flexion contracture","primary":false}],"ledeHtml":"A form of limb-girdle muscular dystrophy most often characterized by an adult onset (but ranging from 11 to 51 years) of mainly proximal lower limb weakness, with difficulties standing on tiptoes being one of the initial signs. Proximal upper limb and distal lower limb weakness is also common, as well as atrophy of the quadriceps (most commonly), biceps brachii, and lower leg muscles. Calf hypertrophy has also been reported in some cases. LGMD2L progresses slowly, with most patients remaining ambulatory until late adulthood.","mondoId":"MONDO:0012652","node":{"canonicalSlug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2l","comparisons":[{"documentSha256":"6a6ea8af2f70fbd3825040b63591d9214825280c493ce7b8536ed4cac9380b03","key":"legacy-limb-girdle-muscular-dystrophy","kind":"legacy","label":"limb-girdle muscular dystrophy","memberIds":["MONDO:0009675","MONDO:0012034","MONDO:0012127","MONDO:0012193","MONDO:0012652","MONDO:0013297","MONDO:0014782","MONDO:0014788","MONDO:0014900","MONDO:0014977","MONDO:0016971","MONDO:0021018","MONDO:0029133","MONDO:0030014","MONDO:0030456","MONDO:0035432","MONDO:0957270","MONDO:0971171"],"mondoId":"MONDO:0016971","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/limb-girdle-muscular-dystrophy.6a6ea8af2f70fbd3825040b63591d9214825280c493ce7b8536ed4cac9380b03.json"},{"documentSha256":"44b063290da75047b19d620af1a4fbd71bbfc833ba8d796f6bf3f1cbd2384659","key":"expanded-limb-girdle-muscular-dystrophy","kind":"expanded","label":"limb-girdle muscular dystrophy","memberIds":["MONDO:0009181","MONDO:0009675","MONDO:0009676","MONDO:0009677","MONDO:0009681","MONDO:0009683","MONDO:0011028","MONDO:0011170","MONDO:0011423","MONDO:0011787","MONDO:0011968","MONDO:0012034","MONDO:0012127","MONDO:0012193","MONDO:0012215","MONDO:0012248","MONDO:0012652","MONDO:0012699","MONDO:0013161","MONDO:0013162","MONDO:0013297","MONDO:0013390","MONDO:0013440","MONDO:0014142","MONDO:0014144","MONDO:0014474","MONDO:0014489","MONDO:0014782","MONDO:0014788","MONDO:0014900","MONDO:0014977","MONDO:0015151","MONDO:0015152","MONDO:0016971","MONDO:0018098","MONDO:0021018","MONDO:0021569","MONDO:0024530","MONDO:0029133","MONDO:0029135","MONDO:0029136","MONDO:0030014","MONDO:0030456","MONDO:0035432","MONDO:0957270","MONDO:0971171"],"mondoId":"MONDO:0016971","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-44b063290da75047b19d.44b063290da75047b19d620af1a4fbd71bbfc833ba8d796f6bf3f1cbd2384659.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Autosomal recessive limb-girdle muscular dystrophy type 2L","originalSourceId":"ORPHA:206549","paragraphs":["A form of limb-girdle muscular dystrophy most often characterized by an adult onset (but ranging from 11 to 51 years) of mainly proximal lower limb weakness, with difficulties standing on tiptoes being one of the initial signs. Proximal upper limb and distal lower limb weakness is also common, as well as atrophy of the quadriceps (most commonly), biceps brachii, and lower leg muscles. Calf hypertrophy has also been reported in some cases. LGMD2L progresses slowly, with most patients remaining ambulatory until late adulthood."],"rawAttribution":"MONDO:0012652","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:39Z","upstream":"MONDO:0012652","url":"https://rarediseases.info.nih.gov/diseases/12536"},"ownColumnKeys":["population-247f283f6bbdb813593d","population-1e29327f424d1e36b1c3"],"publication":"published","relationships":[{"kind":"parent","label":"autosomal recessive limb-girdle muscular dystrophy","mondoId":"MONDO:0015152","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"01d6fbf42f390010f718369683687cef145217083f113f0904d0fcab98615866","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003555","is_excluded":false,"label":"Muscle fiber splitting","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0329096c53dafefc0ad50f6c0c3527e5149cb187f64cede35de9b2bc8307fde8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003445","is_excluded":false,"label":"EMG: neuropathic changes","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"0b232a3e9d9f336362f5548c177b15c75cadbc8f5209b1d11fba8c24610fe239","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:611307","disease_name":"Muscular dystrophy, limb-girdle, type 2L","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003547","is_excluded":false,"label":"Shoulder girdle muscle weakness","onset_id":null,"reference":"OMIM:611307","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"0e90838491f53a6a6521f9919fa88a39efe62b39f9ab7d6749878e3f1daf1432","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0009053","is_excluded":false,"label":"Distal lower limb muscle weakness","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"13001241d627d9ffe344e73bba5d283e9f165ef9d92ef31abe89d3cdddfca438","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008997","is_excluded":false,"label":"Proximal upper limb muscle weakness","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"147f3eb15d664adf2de829ae1dbb3679ff3fb9a7d9076ec550444b81e29cdebe","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008988","is_excluded":false,"label":"Pelvic girdle muscle atrophy","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1adc12fe168274c2bf4a0cc1b9362eae7190875ca742f556ebe369d1fc649510","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0007210","is_excluded":false,"label":"Lower limb amyotrophy","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"1d4a5b316e429d357b4ffda8609280790349421da793d00b6e101ff1334addac","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:611307","disease_name":"Muscular dystrophy, limb-girdle, type 2L","evidence":"PCS","frequency_raw":"6/7","hpo_id":"HP:0009050","is_excluded":false,"label":"Quadriceps muscle atrophy","onset_id":null,"reference":"PMID:20096397","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"290320c0c430593b711ac8532680c524e2222497aca81266442db6764a83a3dd","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003557","is_excluded":false,"label":"Increased variability in muscle fiber diameter","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"2a9a38e27e6b9e632e304a3d159715186b789334280fc5b29805c6947c7f67c2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:611307","disease_name":"Muscular dystrophy, limb-girdle, type 2L","evidence":"PCS","frequency_raw":"4/12","hpo_id":"HP:0008981","is_excluded":false,"label":"Calf muscle hypertrophy","onset_id":null,"reference":"PMID:20096397","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"2dde50dcbacf3f4a1a2b724261d5a576d22011b2ca9e83ed55f7536b2af16abf","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0006785","is_excluded":false,"label":"Limb-girdle muscular dystrophy","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"387a888eca9b4431dc13b39f971e8b8faa7fa73bac234eab1870ed597c553644","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002816","is_excluded":false,"label":"Genu recurvatum","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"473f8293b31a54a2a5529c6187421ee94c4ca50dc566d6fa681f943d2db95adf","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002987","is_excluded":false,"label":"Elbow flexion contracture","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"49622da485569dd12f6ccb335ea74d62eb63e39871ae2f08885835ebc637a733","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0006466","is_excluded":false,"label":"Ankle flexion contracture","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4bb8aa67f617c38fe67808f132c1bcdd46fddd49087eeb8aa79960c29a5a4f3f","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0031237","is_excluded":false,"label":"Internally nucleated skeletal muscle fibers","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5346140069a419c6f09cde66d0e268238e3b14a4a20d7017807d8dee2a8c54c1","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001638","is_excluded":false,"label":"Cardiomyopathy","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"61306359e34a26279371c49116e28df35db45bf1027fa81a2dfd5b3b7410fbf1","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0009050","is_excluded":false,"label":"Quadriceps muscle atrophy","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6c7ae4f5e530546fb2a5f5df89e463e30b74f067411118bfe3874e5799b07b16","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012548","is_excluded":false,"label":"Fatty replacement of skeletal muscle","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"768cf16c9846629f425bab10ad29f4522deaa341c539d98fcea1b8500b44a365","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010628","is_excluded":false,"label":"Facial palsy","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"799bf39dd3527a4655ba759f37924f32ce88805fc00c2e4c907303da7992c53e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:611307","disease_name":"Muscular dystrophy, limb-girdle, type 2L","evidence":"PCS","frequency_raw":"11/12","hpo_id":"HP:0003701","is_excluded":false,"label":"Proximal muscle weakness","onset_id":null,"reference":"PMID:20096397","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"7a82d13e0f16ec092da819aaf8e3a830c5766506f3b665a6ed827e4b645d7a68","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001239","is_excluded":false,"label":"Wrist flexion contracture","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7ceba7a4f158c59416186a2775acbc96a22aaf88fb13c6f22787fe30d9403427","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004303","is_excluded":false,"label":"Abnormal muscle fiber morphology","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8719691e22efab205ef58f543ec25f1275290214a01a142c3d65b4f84baeb79b","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003691","is_excluded":false,"label":"Scapular winging","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"87c74575193596944fb631166f320f189c905d2ac6b6f6f61d731b11101e03f6","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003730","is_excluded":false,"label":"EMG: myotonic runs","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8ba44e0b2a479d57ac99f01598668310377a899f8ea40c08c4ed0d55ebf4fb7f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002913","is_excluded":false,"label":"Myoglobinuria","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8f430c4037e90925c74580a46459b4445a797421a8ca0369ac458ea4995ee214","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"95046e7e8d3be772aeaa217bd833f88e8cb1c3ce1d3fa8509a9a884a0524159b","raw":{"aspect":"P","body_system":"other","disease_id":"OMIM:611307","disease_name":"Muscular dystrophy, limb-girdle, type 2L","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003326","is_excluded":false,"label":"Myalgia","onset_id":null,"reference":"OMIM:611307","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"97ba07d86346667bfc006657068428613218e184f9f89f5ed0f8d6a1aedb326a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:611307","disease_name":"Muscular dystrophy, limb-girdle, type 2L","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0003458","is_excluded":false,"label":"EMG: myopathic abnormalities","onset_id":null,"reference":"OMIM:611307","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"9c9291870ded50f73cce56dfc7b8e8d62be7556077affe174d20cd69886ded6a","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100295","is_excluded":false,"label":"Muscle fiber atrophy","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"9fa1590a795f0aace276badc67656b1560bf845f8cabbc54790c507a74819294","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:611307","disease_name":"Muscular dystrophy, limb-girdle, type 2L","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003560","is_excluded":false,"label":"Muscular dystrophy","onset_id":null,"reference":"PMID:20096397","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"a19afce354b99dc8d3865ba651d74e7f2e4a0af47b618ff55317f44bd860c0cb","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100297","is_excluded":false,"label":"Increased endomysial connective tissue","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"ab52d5b918646968c0a8299555d8833151d9723b72a58bb25622cc9eb178ea09","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:611307","disease_name":"Muscular dystrophy, limb-girdle, type 2L","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0009025","is_excluded":false,"label":"Increased connective tissue","onset_id":null,"reference":"OMIM:611307","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"b4d177e3597687493481d647de1ccefc733e326a29116cdb27234d54c9625f00","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0009129","is_excluded":false,"label":"Upper limb amyotrophy","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b810b5778a04c39d92adaa6fdb23ce38e0227cff198e8a5bd79e71dfc63e6517","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003482","is_excluded":false,"label":"EMG: axonal abnormality","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b9ae9d8893a74b944f6e3ee563be51be8eb0097061c888c13156a0f55cdefeea","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003458","is_excluded":false,"label":"EMG: myopathic abnormalities","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c8000a8a6dd106fbcbbfde05846ebea8766587667c548a28d52f4e7ac5ca73da","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003738","is_excluded":false,"label":"Exercise-induced myalgia","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c801b509d9d49ad7e76ab39c76aecd841a30a28f0f8fd46720446f9b3a127609","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008994","is_excluded":false,"label":"Proximal lower limb muscle weakness","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cafbc823e5cc103579b346ebb434a6f30c64c82d272e6e133caefd24e56dae5c","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012785","is_excluded":false,"label":"Flexion contracture of finger","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cd8b530c1789cdd4763e93ae825e0832fc3b0bd8c538bba27bc3cdf022b287d3","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001371","is_excluded":false,"label":"Flexion contracture","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e917269beff2326c23f06a5c51974d3200a01a71a12430d990b55e3fa76a57ee","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"ede150515d7641817b825b6f7a3132efa181d8dda751c53fd6fd892d0321ddd2","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:611307","disease_name":"Muscular dystrophy, limb-girdle, type 2L","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0003749","is_excluded":false,"label":"Pelvic girdle muscle weakness","onset_id":null,"reference":"PMID:20096397","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"f0a76620cfc8b56d680874b837981bce1ea6d3c22b3b6993c1266e9b9fdd5122","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003089","is_excluded":false,"label":"Hamstring contractures","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"f0bbc5cf52d2a7b69f355c7da3422d1427159dade4e9a5cd2f1d9fc2541ba327","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:611307","disease_name":"Muscular dystrophy, limb-girdle, type 2L","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0010628","is_excluded":false,"label":"Facial palsy","onset_id":null,"reference":"OMIM:611307","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"fa54f1b5753b5f2e519412429b6851f7767d6999d7660d93cf04a7f3b7d85861","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001430","is_excluded":false,"label":"Abnormal calf musculature morphology","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"fd7b48e5f694a95d06120c0f36adc3bf099b0283ea5abee3a92e1598a34aa361","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:611307","disease_name":"Muscular dystrophy, limb-girdle, type 2L","evidence":"PCS","frequency_raw":"12/12","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:20096397","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"fd8446f2439022bfc671bbc42b4998c41865e6bb7ab5906735bb4cf5d5ad7b67","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:206549","disease_name":"Anoctamin-5-related limb-girdle muscular dystrophy R12","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008981","is_excluded":false,"label":"Calf muscle hypertrophy","onset_id":null,"reference":"ORPHA:206549","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12536\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0012652\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0012652</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A form of limb-girdle muscular dystrophy most often characterized by an adult onset (but ranging from 11 to 51 years) of mainly proximal lower limb weakness, with difficulties standing on tiptoes being one of the initial signs. Proximal upper limb and distal lower limb weakness is also common, as well as atrophy of the quadriceps (most commonly), biceps brachii, and lower leg muscles. Calf hypertrophy has also been reported in some cases. LGMD2L progresses slowly, with most patients remaining ambulatory until late adulthood.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12536\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"autosomal-recessive-limb-girdle-muscular-dystrophy-type-2l","sourceDocuments":[{"name":"GARD: Autosomal recessive limb-girdle muscular dystrophy type 2L","reviewed":null,"source_release":"2026-10-25T03:41:39Z","url":"https://rarediseases.info.nih.gov/diseases/12536"},{"name":"MONDO: autosomal recessive limb-girdle muscular dystrophy type 2L","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0012652"}],"sourceNote":"","synonyms":["ANO5 autosomal recessive limb-girdle muscular dystrophy","autosomal recessive limb-girdle muscular dystrophy caused by mutation in ANO5","LGMD2L","limb-girdle muscular dystrophy type 2L","muscular dystrophy, limb-girdle, autosomal recessive 12","muscular dystrophy, limb-girdle, type 2L"],"takeawayHtml":"","title":"autosomal recessive limb-girdle muscular dystrophy type 2L"},"schemaVersion":1}
